These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7286888)
1. Protection by antibiotics against experimental focal cholangitis produced in mice by a schistosomicidal isothiocyanate. Batzinger RP; Bueding E; Popper H Hepatology; 1981; 1(1):21-7. PubMed ID: 7286888 [TBL] [Abstract][Full Text] [Related]
2. [Amoscanate induced liver injury. I. Clinical observation (author's transl)]. Miao HZ Zhonghua Nei Ke Za Zhi; 1981 Jul; 20(7):430-2. PubMed ID: 7327065 [No Abstract] [Full Text] [Related]
3. [Clinical analysis of 21 cases of jaundice caused by nithiocyaminum (amoscanate, C9333 GO/CGP4540) (author's transl)]. Zhonghua Nei Ke Za Zhi; 1980 Mar; 19(2):132-4. PubMed ID: 7472043 [No Abstract] [Full Text] [Related]
4. Efficacy of amoscanate against experimental schistosomal infections in monkeys. Crawford KA; Asch HL; Bruce JI; Bueding E; Smith ER Am J Trop Med Hyg; 1983 Sep; 32(5):1055-64. PubMed ID: 6625061 [TBL] [Abstract][Full Text] [Related]
5. Mutagenic activation of an antischistosomal drug by enteric Streptococcus sps in vitro and in vivo. Molineaux CJ; Batzinger RP; Schmidt W; Bueding E Teratog Carcinog Mutagen; 1980; 1(2):129-39. PubMed ID: 6119805 [TBL] [Abstract][Full Text] [Related]
6. Prevention of the mutagenic activation of an antischistosomal isothiocyanate in primates by an antibiotic. Batzinger RP; Bueding E; Crawford K; Bruce J Environ Mutagen; 1979; 1(4):353-60. PubMed ID: 553807 [TBL] [Abstract][Full Text] [Related]
7. [Side effects on the nervous system caused by nithiocyamine. Clinical observation of 47 cases]. Wu LS; Li F Zhonghua Nei Ke Za Zhi; 1983 Aug; 22(8):477-9. PubMed ID: 6653210 [No Abstract] [Full Text] [Related]
8. [The effect of nithiocyaminum on cardiovascular system in the treatment of schistosomiasis (author's transl)]. Wang ZH Zhonghua Nei Ke Za Zhi; 1981 Jun; 20(6):355-7. PubMed ID: 7318592 [No Abstract] [Full Text] [Related]
9. Clinical evaluation of amoscanate in healthy male volunteers. Shapiro TA; Were JB; Talalay P; Bueding E; Rocco L; Danso K; Massof R; Green R; Mellits ED; Lietman PS Am J Trop Med Hyg; 1986 Sep; 35(5):945-53. PubMed ID: 3766854 [TBL] [Abstract][Full Text] [Related]
10. The immune response to a schistosomacide, amoscanate. I. Serum antibody responses. Barton BE; Levy DA J Immunopharmacol; 1985; 7(3):343-71. PubMed ID: 2414366 [TBL] [Abstract][Full Text] [Related]
11. Conversion of amoscanate to a mutagenic metabolite in gnotobiotic mice implanted with Streptococcus equinus. Reddy BS; Batzinger RP; Molineaux CJ; Bueding E Antimicrob Agents Chemother; 1982 Oct; 22(4):707-8. PubMed ID: 7181482 [TBL] [Abstract][Full Text] [Related]
12. The immune response to a schistosomacide, amoscanate. II. Cell-mediated immune responses. Barton BE; Levy DA J Immunopharmacol; 1985; 7(3):373-83. PubMed ID: 4056413 [TBL] [Abstract][Full Text] [Related]
13. [Clinical observation on schistosomiasis japonica treated with amoscanate and phenithionate in a hyperendemic area]. Zhou GX Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):634-5. PubMed ID: 6673935 [No Abstract] [Full Text] [Related]
14. [Efficacy of amoscanate derivatives in experimental schistosomiasis]. Yue WJ; Shao BR; Pan QR; You JQ; Mei JY Yao Xue Xue Bao; 1983 Jul; 18(7):541-4. PubMed ID: 6659959 [No Abstract] [Full Text] [Related]
15. [Phenithionate(phenyl-4-nitrodiphenylamine-4'-thionocarbamate) in the treatment of schistosomiasis japonicum--a preliminary report on 463 cases]. Liu YH Zhonghua Nei Ke Za Zhi; 1982 Oct; 21(10):609-13. PubMed ID: 7151549 [No Abstract] [Full Text] [Related]
16. [Radioimmunoassay for an antischistosomal drug, 4-nitro-4'-isothiocyano-diphenylamine (7505) (author's transl)]. Wang ZT; Wang DN; Li Q; Ouyang HJ Yao Xue Xue Bao; 1980 Aug; 15(8):463-9. PubMed ID: 7211390 [No Abstract] [Full Text] [Related]
17. Neuropathology of the antischistosomal agent amoscanate administered in high oral doses to rats. Clark AW; Kiel SM; Parhad IM Neurotoxicology; 1982 Nov; 3(3):1-11. PubMed ID: 6891757 [TBL] [Abstract][Full Text] [Related]
18. Amoscanate as a topically applied chemical for prophylaxis against Schistosoma mansoni infections in mice. Greene LK; Grenan MM; Davidson DE; Jones DH; Shedd TR Am J Trop Med Hyg; 1983 Nov; 32(6):1356-63. PubMed ID: 6650736 [TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni: tegumental surface alterations induced by subcurative doses of the schistosomicide amoscanate. Voge M; Bueding E Exp Parasitol; 1980 Oct; 50(2):251-9. PubMed ID: 7409075 [No Abstract] [Full Text] [Related]
20. Comparison of praziquantel, amoscanate and hexachloroparaxylol in clonorchiasis sinensis. Wang QN; Liu JB; Liu YH; Chen RX; Qiu ZD; Qu ZQ Chin Med J (Engl); 1980 Dec; 93(12):849-56. PubMed ID: 6780274 [No Abstract] [Full Text] [Related] [Next] [New Search]